We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.
RJ is a freelance science writer based in Glasgow. He covers biological and biomedical science, with a focus on the complexities and curiosities of the brain and emerging AI technologies. RJ was a science writer at Technology Networks for six years. RJ has a Master’s degree in Clinical Neurosciences from the University of Cambridge.
News of research into the progressive dementia Alzheimer’s disease (AD) often makes for grim reading. Science is yet to find an effective therapy or cure for this debilitating condition.
But this doesn’t mean significant progress hasn’t been made. To mark World Alzheimer’s Day 2020, we have highlighted five areas of research which have seen notable advances that point the way towards effective treatments for AD. In a year which has provided plenty of bad news, here are some reasons to be optimistic about AD research in 2020.
Download this list to read about:
Improvements to our understanding of AD’s genetic architecture
Tests that promise to predict AD years before cognitive symptoms appear
Clinical trials that offer a glimpse of what future AD treatments might look like.
RJ is a freelance science writer based in Glasgow. He covers biological and biomedical science, with a focus on the complexities and curiosities of the brain and emerging AI technologies. RJ was a science writer at Technology Networks for six years. RJ has a Master’s degree in Clinical Neurosciences from the University of Cambridge.